Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development

SARS-COV-2 has roused the scientific community with a call to action to combat the growing pandemic. At the time of this writing, there are as yet no novel antiviral agents or approved vaccines available for deployment as a frontline defense. Understanding the pathobiology of COVID-19 could aid scie...

Descripción completa

Detalles Bibliográficos
Autores principales: Keshavarzi Arshadi, Arash, Webb, Julia, Salem, Milad, Cruz, Emmanuel, Calad-Thomson, Stacie, Ghadirian, Niloofar, Collins, Jennifer, Diez-Cecilia, Elena, Kelly, Brendan, Goodarzi, Hani, Yuan, Jiann Shiun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Artificial Intelligence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861281/
https://www.ncbi.nlm.nih.gov/pubmed/33733182
http://dx.doi.org/10.3389/frai.2020.00065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861281/
https://www.ncbi.nlm.nih.gov/pubmed/33733182
http://dx.doi.org/10.3389/frai.2020.00065

Ejemplares similares